AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia BWednesday, March 10, 2010 @ 1:42AMAmsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
Caliper Life Sciences Reports Fourth Quarter and Full Year 2009 ResultsTuesday, March 9, 2010 @ 8:23AMHOPKINTON, Mass., March 9 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), today reported its fourth quarter and fiscal year 2009 results.
Columbiana theater hosts red carpet event for movie premiereSaturday, March 6, 2010 @ 10:18PMCOLUMBIANA - It was the way going to the theater used to be. Men in suits and shiny shoes; ladies in full evening gowns, their hair done up high on their heads.
Retiring activist nun looks backSaturday, March 6, 2010 @ 7:39PMSister Monica Kostielney announced she is retiring as president of the Michigan Catholic Conference. She shares her thoughts on a 38-year career fighting for life, school choice, fair taxes for the poor, and more.
Heirlooms dissect life of 19th century doctorFriday, March 5, 2010 @ 9:34PMHeirlooms dissect life of 19th century doctor